Towards a global initiative for fibrosis treatment (GIFT)
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterised by increased scarring of lung tissue. Despite the recent introduction of novel drugs that slow disease progression, IPF remains a deadly disease, and the benefits of these new drugs differ markedly between patients. Huma...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2017-12-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/3/4/00106-2017.full |